CN Patent

CN106279074B — 一种化合物及其制备方法和在合成布瓦西坦中的用途

Assigned to Suzhou Pengxu Pharmatech Co ltd · Expires 2018-06-26 · 8y expired

What this patent protects

本申请提供一种式I化合物及其制备方法。本申请还提供式I化合物用于合成布瓦西坦的用途以及合成方法。本申请所述方法涉及的原料易得且价格便宜，可制备出高光学纯度的布瓦西坦。

USPTO Abstract

本申请提供一种式I化合物及其制备方法。本申请还提供式I化合物用于合成布瓦西坦的用途以及合成方法。本申请所述方法涉及的原料易得且价格便宜，可制备出高光学纯度的布瓦西坦。

Drugs covered by this patent

Patent Metadata

Patent number
CN106279074B
Jurisdiction
CN
Classification
—
Expires
2018-06-26
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Pengxu Pharmatech Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.